Martynas Jocys, Baltics marketing director and Lithuania general manager at AstraZeneca, talks about the role that innovation has played in the company’s strategy, the need for increased patient access in Lithuania and the other Baltic countries as well as the launch of new products for oncology, biologics, severe asthma, diabetes, and respiratory diseases.
Can you begin by briefly walking our readers through AstraZeneca’s history?
"There are lots of ideas and we have also come with some proposals to the health authorities about how they should do it."
